3'-Deoxy-3'-[18F] Fluorothymidine PET Imaging in Patients With Cancer — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

3'-Deoxy-3'-[18F] Fluorothymidine PET Imaging in Patients With Cancer — Stella

Recruiting

Back to Brain and Central Nervous System Tumors trials

Trial locations(1 site)

United States

Barbara Ann Karmanos Cancer Institute, Detroit, Michigan

Key details

Sponsor

Barbara Ann Karmanos Cancer Institute

Collaborators

National Cancer Institute (NCI)

Started

September 2009

Primary completion

May 2027

Age range

18 Years – 120 Years

Last updated July 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov